A European Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia Syndrome
A European Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia Syndrome
Investigation of efficacy and safety of treatment with milnacipran in the treatment of fibromyalgia syndrome.
Inclusion Criteria:
Exclusion Criteria:
Cologne, D50931, Germany
Lillehamer, 2609, Norway